Loomis Sayles & CO L P Reata Pharmaceuticals Inc Transaction History

Loomis Sayles & CO L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$93.53 - $163.34 $13.7 Million - $24 Million	-146,783 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $1.63 Million - $2.28 Million	12,894 Added 9.63%	146,783 $22.9 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $2.22 Million - $4.44 Million	17,909 Added 15.44%	133,889 $19.3 Million
Q4 2019 Feb 14, 2020	SELL	$74.57 - $217.92 $7.89 Million - $23.1 Million	-105,803 Reduced 47.71%	115,980 $23.7 Million
Q3 2019 Nov 13, 2019	BUY	$71.26 - $95.75 $1.8 Million - $2.41 Million	25,194 Added 12.82%	221,783 $17.8 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $15.3 Million - $18.5 Million	196,589 New	196,589 $18.5 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.